Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-03-17 @ 10:42 PM
Study NCT ID:
NCT00645892
Status:
COMPLETED
Last Update Posted:
2008-03-28
First Post:
2008-03-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor:
Abbott
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
None
Primary Completion Date:
2004-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2008-03-25
First Submit QC Date:
None
Study First Post Date:
2008-03-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-03-25
Last Update Post Date:
2008-03-28
Last Update Post Date Type:
ESTIMATED